Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: Reckitt surges on infant formula win, Schroders lifted by upgrade
(Sharecast News) - London's FTSE 100 was up 1% at 8,189.25 in afternoon trade on Friday. Reckitt Benckiser surged to the top of the index after its subsidiary Mead Johnson was cleared of liability in a US trial investigating whether it - and Abbott - hid bowel disease risks associated with premature-baby formula.
Russ Mould, investment director at AJ Bell, said: "Consumer goods firm Reckitt enjoyed a meaningful relief rally off the back of a ruling in the latest trial on disease risks associated with its baby formula.
"There has been nothing but bad news on this front for Reckitt for some time so it's not a surprise this chink of light has been seized upon by investors in a positive way. There are still plenty of outstanding cases so this issue will not go away for Reckitt overnight, but it certainly represents a crumb of comfort for long-suffering shareholders.
"An eventual resolution of this issue could be a precursor to selling the Mead Johnson business which has been nothing short of a disaster for Reckitt since it was acquired for $16.6 billion in 2017. The company is already on track to sell a portfolio of home care brands like Air Wick and Cillit Bang by the end of next year as CEO Kris Licht continues his restructure of the business."
Schroders was also in the black as BNP Paribas Exane upgraded the stock to 'outperform' from 'neutral' ahead of third-quarter results next week, as it pointed to improving momentum and an attractive valuation.
"We see these results as a potential strong positive catalyst for the stock where the company will outline positive flows in Q3 and beyond and positive fund performance momentum," it said.
"We also expect some strategic repositioning of the company which could include a cost savings program.
"Finally, we see a better outlook for Schroders' Wealth and alternative businesses as deal activity rebounds."
FTSE 100 - Risers
Reckitt Benckiser Group (RKT) 5,076.00p 8.37% Schroders (SDR) 357.40p 3.90% GSK (GSK) 1,429.00p 2.62% Beazley (BEZ) 774.00p 2.45% Intermediate Capital Group (ICG) 2,106.00p 2.13% Croda International (CRDA) 3,776.00p 1.92% Whitbread (WTB) 3,069.00p 1.86% Legal & General Group (LGEN) 221.10p 1.84% Imperial Brands (IMB) 2,379.00p 1.80% BT Group (BT.A) 140.65p 1.74%
FTSE 100 - Fallers
Smurfit Westrock (DI) (SWR) 3,917.00p -2.44% Smith (DS) (SMDS) 537.50p -1.47% Flutter Entertainment (DI) (FLTR) 18,000.00p -0.77% International Consolidated Airlines Group SA (CDI) (IAG) 209.40p -0.71% CRH (CDI) (CRH) 7,370.00p -0.32% Vistry Group (VTY) 907.00p -0.27% Prudential (PRU) 643.00p -0.25% Sainsbury (J) (SBRY) 265.60p -0.23% JD Sports Fashion (JD.) 123.75p -0.20% Entain (ENT) 744.20p -0.11%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.